PAHC vs KTWO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PAHC Captures Institutional Edge (3โ1 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Phibro Animal Health Corporation Class A (PAHC) driven by superior Valuation, Growth & Margin, Options & Structure while KTWO counters with relative strength in Momentum & Technical. Fundamentally, PAHC trades at 10.0x Forward P/E with 12.7% operating margin (+6.3% YoY revenue) versus KTWO at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, PAHC sits in CONSOLIDATION (9th %ile IV; Dealer Gamma Walls on Pro) against KTWO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PAHC | KTWO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.4B | N/A | Larger Scale | PAHC |
| Trailing P/E Ratio Valuation | 14.2x | N/M | Lower Multiple | PAHC |
| Forward P/E Ratio Valuation | 10.0x | N/M | Lower Multiple | PAHC |
| Revenue Growth (YoY) Growth | +6.3% | N/A | Higher Growth | PAHC |
| Operating Margin (TTM) Profitability | 12.7% | N/A | Higher Margin | PAHC |
| Net Profit Margin Profitability | 6.7% | N/A | Higher Margin | PAHC |
| Return on Equity (ROE) Capital Efficiency | 28.2% | N/A | Higher ROE | PAHC |
| 52-Week Range Position Momentum | 16% ($28โ$60) | 97% ($10โ$10) | Stronger Trend | KTWO |
| Beta / 30D Volatility Risk Regime | 1.04ฮฒ ยท 55% Vol | 0.02ฮฒ ยท 4% Vol | Lower Realized Risk | KTWO |
| Unified Institutional Score Composite Signal | 65.9 / 100 (BUY) | 55.8 / 100 (HOLD) | Higher Composite | PAHC |